Abstract:
An increased level of hospital infections resistance and emergence of new resistance
mechanisms in the conditions of widespread antibiotics use makes serious demands to the quality of
laboratory diagnostics and organization of microbiological monitoring. The objective of the research:
to determine the frequency of the resistant to antibiotics strains of Enterobacteriaceae, Acinetobacter
and Candida species; with the help of phenotypic methods to identify the production of extendedspectrum b-lactamases (ESBL) of different classes and other enzymes and mechanisms providing
resistance. Material for the investigation was presented with 102 strains of K. pneumoniae, E. coli,
A.baumannii and Candida spp., selected from the patients with different pathology treated in
therapeutic departments. The determination of selected isolates was performed with the help of diskdiffusion method according to the recommendations of Clinical and Laboratory Standards Institute
(CLSI). For identification and results control of the sensitivity identification an automatic system
Vitek 2 (Bio Merieux) was used. 27% of the Enterobacteriaceae and Acinetobacter strains showed
resistance to penicillins, 3d and 4th generations of cephalosporins and sensitivity to cephamycins
what confirms the production of ESBL belonging to molecular class A. 16,7% of the same bacteria
were resistant to 3d and 4th generations of cephalosporins, cephamycins, so to reveal ESBL of C
AmpC type. 8,3% of the strains that appeared to be Acinetobacter baumannii, produced
carbapenemases and in this regard were characterized by a high resistance level to 3d and 4th
generations of cephalosporins and carbapenems. 16,7% of the strains produced penicillinases and
2,1%- cephalosporinases. Aminoglycoside-modifying enzymes were found in 33,3% cases.
Resistance to ftorchinolones was equal to ciprofloxacin, norfloxacin and ofloxacin and was noticed in
38, 5% of the tested strains. Candida species were more resistant to azole antifungal drugs (50% of
fluconazole-resistant strains) then to polyens (20, 3% nystatin-resistant) according to disk-diffusion
method. The results of Candida resistance obtained from disk-diffusion method were not confirmed
by the following Vitek study that can be explained by the absence of CLSI disk-diffusion method
recommendations for non-albicans strains.
